Navigation Links
Gastroenterology special issue focuses on new directions of viral hepatitis care and research
Date:5/15/2012

The editors of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue. Published each May, the 13th issue is devoted to a particular gastroenterological topic of broad interest; this year's topic is viral hepatitis.

In conjunction with editor-in-chief M. Bishr Omary, MD, PhD, this issue was developed by Gastroenterology's experts in viral hepatitis: Senior Associate Editor Anna S. Lok, MD, AGAF, and Associate Editor Jean-Michel Pawlotsky, MD, PhD. Their expertise guided the contributing authors an outstanding group of thoughtful expert international leaders.

"Our goals in this special issue of Gastroenterology are to give readers an up-to-date insight into the tremendous progress made over the past few years in viral hepatitis research and care, and to guide them through complex challenges and expected future developments," said the editors.

In this year's issue, classic review articles are interspersed with insightful commentaries that address critical unresolved issues and fundamental questions for the future. The content is organized into four sections, mainly related to hepatitis B virus and hepatitis C virus (HCV) infections: epidemiology and pathophysiology; diagnostic and prognostic tools; therapy and prevention; and hepatitis E virus, a neglected virus that was recently found to be clinically important in industrialized countries.

No other field in hepatology and gastroenterology has grown more rapidly than viral hepatitis in the past 15 years, thanks to the considerable interest of the scientific community for diseases that involve more than 500 million patients worldwide; active support for research from governments in the U.S., Europe, Japan and Australia; and major drug industry investment for what promises to be an incredibly rewarding market for antiviral drugs. This issue not only contains classical review articles dealing with important areas for which major advances have occurred recently, but editorial-like commentaries exploring critical unresolved issues and fundamental questions for the future. The commentaries, reviews and their distinguished authors are as follows:

Commentaries

  • "Is Hepatitis C Virus Carcinogenic?" by Stanley M. Lemon and David R. McGivern
  • "HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?" by Francesco Negro
  • "Genetic Factors and Hepatitis C Virus Infection" by Alexander J. Thompson
  • "Will Interferon-Free Regimens Prevail?" by Christoph Welsch and Stefan Zeuzem
  • "Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?" by Jordan J. Feld
  • "Is Hepatitis Virus Resistance to Antiviral Drugs a Threat?" by Jean-Michel Pawlotsky
  • "Will There Be a Vaccine to Protect Against the Hepatitis C Virus?" by Benot Callendret and Christopher M. Walker

Reviews

  • "Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma" by Hashem B. El-Serag
  • "Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease" by Jens Bukh
  • "Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C" by Laurent Castera
  • "New Virologic Tools for Management of Chronic Hepatitis B and C" by Stphane Chevaliez, Christophe Rodriguez and Jean-Michel Pawlotsky
  • "Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus" by A. Sidney Barritt and Michael W. Fried
  • "Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals" by Susanna Naggie and Mark S. Sulkowski
  • "Anti-Hepatitis C Virus Drugs in Development" by Esperance A.K. Schaefer and Raymond T. Chung
  • "Effectiveness of Hepatitis B Treatment in Clinical Practice" by Steven J. Scaglione and Anna S.F. Lok
  • "Viral Hepatitis in Liver Transplantation" by Gonzalo Crespo, Zoe Mario, Miquel Navasa and Xavier Forns
  • "Pathogenesis and Treatment of Hepatitis E Virus Infection" by Heiner Wedemeyer, Sven Pischke and Michael P. Manns

"We hope this supplementary issue will provide the readers with useful and up-to-date information to understand the new directions of viral hepatitis care and research, and the formidable remaining challenges," stated Drs. Lok and Pawlotsky.


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Unique gastroenterology procedure developed in adults shows promise in pediatrics
2. Arab Journal of Gastroenterology accepted for MEDLINE indexing
3. Product Innovators Launch Unique Sensory Tool for Special Needs Youth
4. Multi-Award Winning Author Tina Turbin Interviews Special Guest Dr. Peter H.R. Green, M.D. On The Thrive in Balance Radio Show
5. Solutions for Sleep Problems: Harvard's Improving Sleep Special Health Report and New Sleep Apnea Video
6. Orthopaedic Physician Dr. Brett Smith Joins Baptist Health Care as Total Joint Specialist
7. Quitting smoking especially difficult for select groups
8. Kars4Kids and Newark Beth Israel Distribute Special Gifts at Children's Hospital
9. Special Olympics Georgia Receives Grant from The Home Depot Foundation
10. Special issue of NeuroRehabilitation focuses on hypoxic-ischemic brain injuries
11. Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: